Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 1
2013 1
2014 1
2015 2
2017 1
2018 1
2019 1
2020 4
2021 7
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Multidrug-resistant tuberculosis.
Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR Jr, Murray M, Lange C. Dheda K, et al. Among authors: mirzayev f. Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2. Nat Rev Dis Primers. 2024. PMID: 38523140 Review.
Bridging the gap: key evidence needed to strengthen global policies to end TB.
Gebreselassie N, Falzon D, Zignol M, Viney K, Ismail N, Mirzayev F, Mavhunga F, Kasaeva T. Gebreselassie N, et al. Among authors: mirzayev f. Int J Tuberc Lung Dis. 2022 Aug 1;26(8):704-707. doi: 10.5588/ijtld.22.0153. Int J Tuberc Lung Dis. 2022. PMID: 35898130 No abstract available.
World Health Organization treatment outcome definitions for tuberculosis: 2021 update.
Linh NN, Viney K, Gegia M, Falzon D, Glaziou P, Floyd K, Timimi H, Ismail N, Zignol M, Kasaeva T, Mirzayev F. Linh NN, et al. Among authors: mirzayev f. Eur Respir J. 2021 Aug 19;58(2):2100804. doi: 10.1183/13993003.00804-2021. Print 2021 Aug. Eur Respir J. 2021. PMID: 34413124 Free article. No abstract available.
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.
Hasan T, Medcalf E, Nyang'wa BT, Egizi E, Berry C, Dodd M, Foraida S, Gegia M, Li M, Mirzayev F, Morgan H, Motta I, Nguyen L, Schumacher S, Schlub T, Fox G. Hasan T, et al. Among authors: mirzayev f. Clin Infect Dis. 2024 Mar 20;78(3):730-741. doi: 10.1093/cid/ciad653. Clin Infect Dis. 2024. PMID: 37874021 Free PMC article. Review.
30 results